Killeen M T, Greenblatt J F
Department of Molecular and Medical Genetics, University of Toronto, Ontario, Canada.
Mol Cell Biol. 1992 Jan;12(1):30-7. doi: 10.1128/mcb.12.1.30-37.1992.
RAP30/74 is a human general transcription factor that binds to RNA polymerase II and is required for initiation of transcription in vitro regardless of whether the promoter has a recognizable TATA box (Z. F. Burton, M. Killeen, M. Sopta, L. G. Ortolan, and J. F. Greenblatt, Mol. Cell. Biol. 8:1602-1613, 1988). Part of the amino acid sequence of RAP30, the small subunit of RAP30/74, has limited homology with part of Escherichia coli sigma 70 (M. Sopta, Z. F. Burton, and J. Greenblatt, Nature (London) 341:410-414, 1989). To determine which sigmalike activities of RAP30/74 could be attributed to RAP30, we purified human RAP30 and a RAP30-glutathione-S-transferase fusion protein that had been produced in E. coli. Bacterially produced RAP30 bound to RNA polymerase II in the absence of RAP74. Both partially purified natural RAP30/74 and recombinant RAP30 prevented RNA polymerase II from binding nonspecifically to DNA. In addition, nonspecific transcription by RNA polymerase II was greatly inhibited by RAP30-glutathione-S-transferase. DNA-bound RNA polymerase II could be removed from DNA by partially purified RAP30/74 but not by bacterially expressed RAP30. Thus, the ability of RAP30/74 to recruit RNA polymerase II to a promoter-bound preinitiation complex may be an indirect consequence of its ability to suppress nonspecific binding of RNA polymerase II to DNA.
RAP30/74是一种人类通用转录因子,它与RNA聚合酶II结合,并且在体外转录起始过程中是必需的,无论启动子是否具有可识别的TATA框(Z.F.伯顿、M.基林、M.索普塔、L.G.奥尔托兰和J.F.格林布拉特,《分子细胞生物学》8:1602 - 1613,1988年)。RAP30/74的小亚基RAP30的部分氨基酸序列与大肠杆菌σ70的部分序列具有有限的同源性(M.索普塔、Z.F.伯顿和J.格林布拉特,《自然》(伦敦)341:410 - 414,1989年)。为了确定RAP30/74的哪些类σ活性可归因于RAP30,我们纯化了人RAP30和在大肠杆菌中产生的RAP30 - 谷胱甘肽 - S - 转移酶融合蛋白。在没有RAP74的情况下,细菌产生的RAP30与RNA聚合酶II结合。部分纯化的天然RAP30/74和重组RAP30都能防止RNA聚合酶II非特异性地与DNA结合。此外,RAP30 - 谷胱甘肽 - S - 转移酶极大地抑制了RNA聚合酶II的非特异性转录。部分纯化的RAP30/74可以将与DNA结合的RNA聚合酶II从DNA上移除,但细菌表达的RAP30则不能。因此,RAP30/74将RNA聚合酶II募集到启动子结合的预起始复合物的能力可能是其抑制RNA聚合酶II与DNA非特异性结合能力的间接结果。